NF-κB activates the IRF4 transcription factor through BCR, CD40, and TLR signaling pathways and plays a critical role in B-cell differentiation and the pathogenesis of DLBCL [71]. This evidence concerns the gene NFKB1 and diffuse large B-cell lymphoma.